Symvess® | Humacyte

Symvess® is an acellular tissue engineered vessel-tyod, a first-in-class, bioengineered human vessel for extremity arterial trauma. It’s the first indication to receive the FDA’s Regenerative Medicine Advanced Therapy (RMAT) expedited review designation and received priority designation for the treatment of extremity arterial repair by the U.S. Secretary of Defense.

This product has received FDA approval.